Literature DB >> 6609964

Homing of Lyt-2+ and Lyt-2- T cell subsets and B lymphocytes to the central nervous system of mice with acute experimental allergic encephalomyelitis.

J Trotter, L Steinman.   

Abstract

Subpopulations of lymphoid cells were compared with respect to their ability to migrate into the central nervous system (CNS) of mice with acute experimental allergic encephalomyelitis (EAE). In mice with established lesions, the majority of cells homing to the CNS are not presensitized to CNS antigens. B cells had a much reduced capacity to migrate into the CNS of sick mice compared with T cells. However, T cells of both the Lyt-2+ and Lyt-2- subsets homed equally well to the CNS. The relative paucity of B cells in the lesions of EAE and multiple sclerosis may thus partly result from the limited ability of these cells to migrate into the CNS across the blood-brain endothelial barrier. The predominance of Lyt-2- T cells over Lyt-2+ cells in these CNS lesions is unlikely to result from such a difference in homing capacity, but may reflect the ratio of these two cell types in the blood or preferential in situ expansion of the Lyt-2- population.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609964

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Pathophysiology of the blood-brain barrier.

Authors:  K Selmaj
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology.

Authors:  Mariana Silva; Ronald Kam Fai Fung; Conor Brian Donnelly; Paula Alexandra Videira; Robert Sackstein
Journal:  J Immunol       Date:  2017-03-22       Impact factor: 5.422

3.  Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.

Authors:  J Masuyama; N Minato; S Kano
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

4.  Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment.

Authors:  S Brocke; C Piercy; L Steinman; I L Weissman; T Veromaa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

5.  Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice.

Authors:  J E Merrill; D H Kono; J Clayton; D G Ando; D R Hinton; F M Hofman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

6.  Relapsing experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice.

Authors:  F D Lublin; R L Knobler; P C Doherty; R Korngold
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

7.  Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier.

Authors:  P Brundin; H Widner; O G Nilsson; R E Strecker; A Björklund
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

8.  Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse.

Authors:  B J Steffen; E C Butcher; B Engelhardt
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

9.  The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rat: distinct nature of parenchymal and perivascular infiltrates.

Authors:  J Lannes-Vieira; J Gehrmann; G W Kreutzberg; H Wekerle
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study.

Authors:  R F Lin; T S Lin; R G Tilton; A H Cross
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.